カテゴリー： Market Monitor Global, 世界, 医療/バイオ

複合化学療法の世界市場見通し2023年-2029年

◆英語タイトル：Compounding Chemotherapy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2174）

◆商品コード：MMG23FB2174
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：103
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の複合化学療法市場規模と予測を収録しています。・世界の複合化学療法市場：売上、2018年-2023年、2024年-2029年
・世界の複合化学療法市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の複合化学療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「重量式自動調合装置（重量式）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

複合化学療法のグローバル主要企業は、Braun Melsungen AG、Pfizer Inc.、Baxter、Grifols SA、The Metrix Company、Added Pharma、Equashield、Millers Pharmacy、Comecer S.P.A.、Omnicell、Icon group、Dedalus Group、Arxium、Sterline S.R.L.、Loccioniなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、複合化学療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の複合化学療法市場：タイプ別、2018年-2023年、2024年-2029年
世界の複合化学療法市場：タイプ別市場シェア、2022年
・重量式自動調合装置（重量式）、容量式自動調合装置（容積式）

世界の複合化学療法市場：用途別、2018年-2023年、2024年-2029年
世界の複合化学療法市場：用途別市場シェア、2022年
・乳がん、血液がん、前立腺がん、消化器がん、呼吸器・肺がん、その他

世界の複合化学療法市場：地域・国別、2018年-2023年、2024年-2029年
世界の複合化学療法市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における複合化学療法のグローバル売上、2018年-2023年
・主要企業における複合化学療法のグローバル売上シェア、2022年
・主要企業における複合化学療法のグローバル販売量、2018年-2023年
・主要企業における複合化学療法のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Braun Melsungen AG、Pfizer Inc.、Baxter、Grifols SA、The Metrix Company、Added Pharma、Equashield、Millers Pharmacy、Comecer S.P.A.、Omnicell、Icon group、Dedalus Group、Arxium、Sterline S.R.L.、Loccioni

*************************************************************

・調査・分析レポートの概要
複合化学療法市場の定義
市場セグメント
世界の複合化学療法市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の複合化学療法市場規模
世界の複合化学療法市場規模：2022年 VS 2029年
世界の複合化学療法市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの複合化学療法の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の複合化学療法製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：重量式自動調合装置（重量式）、容量式自動調合装置（容積式）
複合化学療法のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：乳がん、血液がん、前立腺がん、消化器がん、呼吸器・肺がん、その他
複合化学療法の用途別グローバル売上・予測

・地域別市場分析
地域別複合化学療法市場規模 2022年と2029年
地域別複合化学療法売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Braun Melsungen AG、Pfizer Inc.、Baxter、Grifols SA、The Metrix Company、Added Pharma、Equashield、Millers Pharmacy、Comecer S.P.A.、Omnicell、Icon group、Dedalus Group、Arxium、Sterline S.R.L.、Loccioni
...

The compounding chemotherapy market is showing significant growth. Compounding of drugs makes them patient-specific which is the biggest advantage. Compounding chemotherapy can minimize the risk of underdose or overdose of drugs for a patient. Therefore, owing to its numerous advantages.
This report aims to provide a comprehensive presentation of the global market for Compounding Chemotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounding Chemotherapy. This report contains market size and forecasts of Compounding Chemotherapy in global, including the following market information:
Global Compounding Chemotherapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Compounding Chemotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Gravimetric Automated Compounding Device (Weight-Based) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Compounding Chemotherapy include Braun Melsungen AG, Pfizer Inc., Baxter, Grifols SA, The Metrix Company, Added Pharma, Equashield, Millers Pharmacy and Comecer S.P.A., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Compounding Chemotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Compounding Chemotherapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Compounding Chemotherapy Market Segment Percentages, by Type, 2022 (%)
Gravimetric Automated Compounding Device (Weight-Based)
Volumetric Automated Compounding Device (Volume-Based)
Global Compounding Chemotherapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Compounding Chemotherapy Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Blood Cancer
Prostate Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Others
Global Compounding Chemotherapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Compounding Chemotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Compounding Chemotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Compounding Chemotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Braun Melsungen AG
Pfizer Inc.
Baxter
Grifols SA
The Metrix Company
Added Pharma
Equashield
Millers Pharmacy
Comecer S.P.A.
Omnicell
Icon group
Dedalus Group
Arxium
Sterline S.R.L.
Loccioni
Outline of Major Chapters:
Chapter 1: Introduces the definition of Compounding Chemotherapy, market overview.
Chapter 2: Global Compounding Chemotherapy market size in revenue.
Chapter 3: Detailed analysis of Compounding Chemotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Compounding Chemotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Compounding Chemotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Compounding Chemotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Compounding Chemotherapy Overall Market Size
2.1 Global Compounding Chemotherapy Market Size: 2022 VS 2029
2.2 Global Compounding Chemotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Compounding Chemotherapy Players in Global Market
3.2 Top Global Compounding Chemotherapy Companies Ranked by Revenue
3.3 Global Compounding Chemotherapy Revenue by Companies
3.4 Top 3 and Top 5 Compounding Chemotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Compounding Chemotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Compounding Chemotherapy Players in Global Market
3.6.1 List of Global Tier 1 Compounding Chemotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Compounding Chemotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Compounding Chemotherapy Market Size Markets, 2022 & 2029
4.1.2 Gravimetric Automated Compounding Device (Weight-Based)
4.1.3 Volumetric Automated Compounding Device (Volume-Based)
4.2 By Type – Global Compounding Chemotherapy Revenue & Forecasts
4.2.1 By Type – Global Compounding Chemotherapy Revenue, 2018-2023
4.2.2 By Type – Global Compounding Chemotherapy Revenue, 2024-2029
4.2.3 By Type – Global Compounding Chemotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Compounding Chemotherapy Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Blood Cancer
5.1.4 Prostate Cancer
5.1.5 Gastrointestinal Cancer
5.1.6 Respiratory/Lung Cancer
5.1.7 Others
5.2 By Application – Global Compounding Chemotherapy Revenue & Forecasts
5.2.1 By Application – Global Compounding Chemotherapy Revenue, 2018-2023
5.2.2 By Application – Global Compounding Chemotherapy Revenue, 2024-2029
5.2.3 By Application – Global Compounding Chemotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Compounding Chemotherapy Market Size, 2022 & 2029
6.2 By Region – Global Compounding Chemotherapy Revenue & Forecasts
6.2.1 By Region – Global Compounding Chemotherapy Revenue, 2018-2023
6.2.2 By Region – Global Compounding Chemotherapy Revenue, 2024-2029
6.2.3 By Region – Global Compounding Chemotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Compounding Chemotherapy Revenue, 2018-2029
6.3.2 US Compounding Chemotherapy Market Size, 2018-2029
6.3.3 Canada Compounding Chemotherapy Market Size, 2018-2029
6.3.4 Mexico Compounding Chemotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Compounding Chemotherapy Revenue, 2018-2029
6.4.2 Germany Compounding Chemotherapy Market Size, 2018-2029
6.4.3 France Compounding Chemotherapy Market Size, 2018-2029
6.4.4 U.K. Compounding Chemotherapy Market Size, 2018-2029
6.4.5 Italy Compounding Chemotherapy Market Size, 2018-2029
6.4.6 Russia Compounding Chemotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Compounding Chemotherapy Market Size, 2018-2029
6.4.8 Benelux Compounding Chemotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Compounding Chemotherapy Revenue, 2018-2029
6.5.2 China Compounding Chemotherapy Market Size, 2018-2029
6.5.3 Japan Compounding Chemotherapy Market Size, 2018-2029
6.5.4 South Korea Compounding Chemotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Compounding Chemotherapy Market Size, 2018-2029
6.5.6 India Compounding Chemotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Compounding Chemotherapy Revenue, 2018-2029
6.6.2 Brazil Compounding Chemotherapy Market Size, 2018-2029
6.6.3 Argentina Compounding Chemotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Compounding Chemotherapy Revenue, 2018-2029
6.7.2 Turkey Compounding Chemotherapy Market Size, 2018-2029
6.7.3 Israel Compounding Chemotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Compounding Chemotherapy Market Size, 2018-2029
6.7.5 UAE Compounding Chemotherapy Market Size, 2018-2029
7 Compounding Chemotherapy Companies Profiles
7.1 Braun Melsungen AG
7.1.1 Braun Melsungen AG Company Summary
7.1.2 Braun Melsungen AG Business Overview
7.1.3 Braun Melsungen AG Compounding Chemotherapy Major Product Offerings
7.1.4 Braun Melsungen AG Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.1.5 Braun Melsungen AG Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Compounding Chemotherapy Major Product Offerings
7.2.4 Pfizer Inc. Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Baxter
7.3.1 Baxter Company Summary
7.3.2 Baxter Business Overview
7.3.3 Baxter Compounding Chemotherapy Major Product Offerings
7.3.4 Baxter Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.3.5 Baxter Key News & Latest Developments
7.4 Grifols SA
7.4.1 Grifols SA Company Summary
7.4.2 Grifols SA Business Overview
7.4.3 Grifols SA Compounding Chemotherapy Major Product Offerings
7.4.4 Grifols SA Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.4.5 Grifols SA Key News & Latest Developments
7.5 The Metrix Company
7.5.1 The Metrix Company Company Summary
7.5.2 The Metrix Company Business Overview
7.5.3 The Metrix Company Compounding Chemotherapy Major Product Offerings
7.5.4 The Metrix Company Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.5.5 The Metrix Company Key News & Latest Developments
7.6 Added Pharma
7.6.1 Added Pharma Company Summary
7.6.2 Added Pharma Business Overview
7.6.3 Added Pharma Compounding Chemotherapy Major Product Offerings
7.6.4 Added Pharma Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.6.5 Added Pharma Key News & Latest Developments
7.7 Equashield
7.7.1 Equashield Company Summary
7.7.2 Equashield Business Overview
7.7.3 Equashield Compounding Chemotherapy Major Product Offerings
7.7.4 Equashield Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.7.5 Equashield Key News & Latest Developments
7.8 Millers Pharmacy
7.8.1 Millers Pharmacy Company Summary
7.8.2 Millers Pharmacy Business Overview
7.8.3 Millers Pharmacy Compounding Chemotherapy Major Product Offerings
7.8.4 Millers Pharmacy Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.8.5 Millers Pharmacy Key News & Latest Developments
7.9 Comecer S.P.A.
7.9.1 Comecer S.P.A. Company Summary
7.9.2 Comecer S.P.A. Business Overview
7.9.3 Comecer S.P.A. Compounding Chemotherapy Major Product Offerings
7.9.4 Comecer S.P.A. Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.9.5 Comecer S.P.A. Key News & Latest Developments
7.10 Omnicell
7.10.1 Omnicell Company Summary
7.10.2 Omnicell Business Overview
7.10.3 Omnicell Compounding Chemotherapy Major Product Offerings
7.10.4 Omnicell Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.10.5 Omnicell Key News & Latest Developments
7.11 Icon group
7.11.1 Icon group Company Summary
7.11.2 Icon group Business Overview
7.11.3 Icon group Compounding Chemotherapy Major Product Offerings
7.11.4 Icon group Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.11.5 Icon group Key News & Latest Developments
7.12 Dedalus Group
7.12.1 Dedalus Group Company Summary
7.12.2 Dedalus Group Business Overview
7.12.3 Dedalus Group Compounding Chemotherapy Major Product Offerings
7.12.4 Dedalus Group Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.12.5 Dedalus Group Key News & Latest Developments
7.13 Arxium
7.13.1 Arxium Company Summary
7.13.2 Arxium Business Overview
7.13.3 Arxium Compounding Chemotherapy Major Product Offerings
7.13.4 Arxium Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.13.5 Arxium Key News & Latest Developments
7.14 Sterline S.R.L.
7.14.1 Sterline S.R.L. Company Summary
7.14.2 Sterline S.R.L. Business Overview
7.14.3 Sterline S.R.L. Compounding Chemotherapy Major Product Offerings
7.14.4 Sterline S.R.L. Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.14.5 Sterline S.R.L. Key News & Latest Developments
7.15 Loccioni
7.15.1 Loccioni Company Summary
7.15.2 Loccioni Business Overview
7.15.3 Loccioni Compounding Chemotherapy Major Product Offerings
7.15.4 Loccioni Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.15.5 Loccioni Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 複合化学療法の世界市場見通し2023年-2029年(Compounding Chemotherapy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

複合化学療法の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp